← All trials
NCT07285148
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 30, 2026
- Primary completion
- Dec 31, 2029
- Completion date
- Dec 31, 2029
- First posted
- Dec 16, 2025
- Last posted
- Dec 16, 2025
- Enrollment
- 253
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Beijing Pearl Biotechnology Limited Liability CompanyLead sponsor
- Avistone Biotechnology Co., Ltd.Collaborator
Drugs studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.